dCas9 Broadens the Application Scope of CRISPR    

CRISPR/Cas9 is a popular gene editing tool that cleaves DNA using Cas9's endonuclease activity. Cas9 becomes inactive due to mutations in its RuvC and HNH domains, yet it still binds DNA with guide RNA to generate dCas9. By combining inhibitory/activating proteins with dCas9, CRISPRa/CRISPRi is generated, which modifies the chromatin at target enhancers and promoters to control the transcription of genes.

CRISPRi: Controlling Gene Expression at the Transcriptional Level

Mechanism of CRISPRi

Target genomic DNA sequences are bound by dCas9, which then creates a spatial hindrance to prevent other DNA-binding proteins including RNA polymerase II and endogenous transcription factors from acting. This technique of interference efficiently suppresses gene expression, offering a reversible approach to gene control.

Figure 1. The mechanism of CRISPRi and different types of CRISPRi inhibition systems (a) The mechanism of CRISPRi inhibits gene transcription (b) ThedCas9-KRAB system (c) The dCas9-LSDl system. (Tian et al., 2018)

Variants of CRISPRi

dCas9-KRAB: This tool inhibits the expression of some genes by combining dCas9 with the KRAB (Krüppel-associated box) domain. By using RNA guidance, dCas9-KRAB may be targeted to particular genes and made to express less of them. It could also affect enhancers and other gene regulatory elements that change chromatin accessibility and suppress gene expression.

dCas9-DNMT3A: This variation silences genes by combining dCas9 with the DNA methyltransferase (DNMT) catalytic domain. This results in DNA methylation at gene promoter regions. Its off-target effects, however, could make it less useful.

dCas9-HDAC: This technique suppresses gene expression by reducing the levels of histone acetylation at particular gene regulatory areas by combining dCas9 with histone deacetylase (HDAC). It's been used to research how histone changes affect biological functions.

CRISPRoff: Using DNMT3A, DNMT3L, and KRAB, CRISPRoff quickly and very selectively causes DNA methylation and gene suppression. When it comes to epigenetic alterations, it provides more stability and versatility than other CRISPRi techniques.

CRISPRa: Activating Gene Expression at the Transcriptional Level

Mechanism of CRISPRa

dCas9 recruits transcriptional activators to target genomic loci, promoting gene transcription. Mammalian cells may activate both reporter and endogenous genes with a single sgRNA when dCas9 is fused with activator domains such as VP64 or p65 (p65AD). However, numerous sgRNAs are frequently needed for considerable gene activation.

Figure 2. The mechanism of CRISPRa and different types of CRISPRa activation systems (a) The mechanism of CRISPRa activates gene transcription (b) The dCas9-VP64 system (c) The dCas9-VPR or (VP16) system (d) The dCas9-SunTag system (e) The SAM system (f) The dCas9-p300core system. (Tian et al., 2018)

Variants of CRISPRa

dCas9-VP64: By using the VP64 domain, which is sourced from the herpes simplex virus 16, dCas9-VP64 may efficiently trigger targeted gene expression. Numerous sectors, including HIV/AIDS therapy and illness treatment, have shown promise.

dCas9-VPR: Target gene expression may be triggered by dCas9-VPR by including the P65 transcription factor. Combining dCas9-VP64 and MS2-p65-HSF1 to create the CRISPRa-SAM system has demonstrated potential in improving antiviral activity and modifying the expression of lncRNAs and protein-coding genes.

dCas9-p300: This variation promotes histone acetylation at target loci by combining dCas9 with the p300 histone acetyltransferase, hence aiding in gene activation. It has been widely applied to the identification and characterization of gene regulatory elements, offering insights into the control of gene expression.

dCas9-dMSK1: dCas9-dMSK1 efficiently induces gene expression by improving histone phosphorylation at target locations through the catalysis of phosphorylation. With the use of these instruments, epigenetic editing may be used in innovative ways to investigate histone phosphorylation and gene regulation.

Future Directions

Derived from CRISPR/Cas9, the CRISPRa and CRISPRi systems, respectively, activate and repress genes. They are extensively employed in genome-wide screening, gene activation, stem cell differentiation, and genetic defect compensation. They have opportunities for advancement, however, despite their advantages, they have drawbacks such as off-target effects and mutation risks during DNA cleavage and repair. Upcoming studies seek to improve the efficiency and specificity of dCas9-mediated gene regulation, opening the door for a variety of uses in biotechnology, medicine, and other fields.

Investigating CRISPR/dCas9: Opening Up Genetic Options with Creative Biogene CRISPR Platform^CB

Discover CRISPR Platform^CB from Creative Biogene's extensive array of CRISPR technology offerings. From basic CRISPR services to sophisticated genome editing for both plants and animals, we have it all.

• Tools for CRISPRi and CRISPRa Genome Editing:

We provide a variety of optimized genome editing tools, such as donor DNA templates, Cas9 protein variants, and plasmids for CRISPR-Cas9 expression, for CRISPRi and CRISPRa applications. With the ability to precisely manipulate gene expression and regulatory elements, these tools open up new avenues for creative research in the fields of synthetic biology, gene therapy, and drug discovery.

• CRISPRi and CRISPRa Screening Libraries:

For high-throughput functional genomics research, we offer pre-designed or custom CRISPRi and CRISPRa screening libraries. These libraries enable researchers to systematically study gene function and regulatory networks because they contain extensive sgRNA collections that target particular gene sets or regulatory elements.

• Analysis Kits for CRISPRi and CRISPRa:

These kits include everything required to evaluate the effectiveness and selectivity of CRISPRi and CRISPRa-mediated gene regulation. Target genes can be thoroughly functionally characterized with the help of these kits, which contain reagents for assessing protein-DNA interactions, chromatin accessibility, and gene expression levels.

CRISPR Platform^CB's Technical Advantages in CRISPR/dCas9

• Higher Transcriptional Activation Efficiency: We continuously optimize experimental conditions and evaluate changes in transcriptional levels through techniques such as quantitative PCR and RNA sequencing. Our focus lies on enhancing gene expression levels and the duration of transcriptional activation, rather than solely delivering results.
• Enhanced Specificity: We have specifically improved gRNA design algorithms and dCas9 structure. We aim to increase its specificity and efficiency by evaluating the nonspecific effects on other genomic regions.
• Lower Cellular Toxicity: The cytotoxicity and effects of dCas9 and its bound gRNA on cells, including aspects like cell viability, proliferation potential, and morphology, are carefully investigated. Our goal is to reduce adverse effects on cells.
• High Reproducibility: To guarantee the repeatability and stability of the dCas9 technology application, we thoroughly validate every stage of the process. We make an effort to ensure that results are consistent and repeatable under various experimental settings.
• Wide Applicability: With more than 500 distinct cell lines, our scientific team has vast experience. They have extensive knowledge of these cell lines' culture conditions and genetic backgrounds, including both readily transfectable and challenging-to-transfect cell lines. Our technology can be used in different cell types and experimental settings because of this wide range of expertise.

Related Services and Products

Services

CRISPRi Stable Cell Lines
CRISPRa Stable Cell Lines
SgRNA Design and Confirmation
Custom CRISPRi sgRNA Vectors
Custom CRISPRa sgRNA Vectors

Products

pCDNA-dCas9-VP64
dCas9-VP64_GFP
pHR-SFFV-dCas9-BFP-KRAB